ANL Competitors & Alternatives
Compare Adlai Nortye Ltd. American Depositary Shares with similar stocks in the same industry
Biotechnology
ANL
Main Stock$9.97
-6.03%
Tradestie Score
48
Revenue Growth
178.1%
Analyst Upside
+195.9%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Drug Design
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TBPH
Theravance Biopharma, Inc.
|
$17.03
|
$726.21M | 16.4 | 51 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$15.01
-3.04%
|
$718.62M | 6.4 | 52 | Compare |
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$19.77
-1.27%
|
$715.25M | - | 31 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
+0.19%
|
$704.73M | - | 51 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$145.03
-4.89%
|
$699.30M | - | 49 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
+0.04%
|
$683.46M | - | 49 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$8.85
-3.59%
|
$665.30M | 10.1 | 46 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$14.95
-4.57%
|
$626.91M | - | 35 | Compare |
|
SVRA
Savara Inc.
|
$4.43
-4.63%
|
$611.84M | - | 56 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
+0.04%
|
$608.81M | - | 49 | Compare |
More ANL Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC None)
220 stocks in this industry